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Atrial fibrillation an uncommon cause of acute coronary syndrom due
to coronary embolism: about 12 cases
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Atrial fibrillation is a common entity and can be associated with thrombo-
embolic complications as many as 18% of patients per year. A coronary
thromboembolus with subsequent myocardial infarction, however, is rare.
Methods and results: We conducted a retrospective descriptive study of
12 patients hospitalized for myocardial infarction with angiographically
normal coronary arteries and atrial fibrillation. This study aims to investi-
gate the epidemiological, clinical, and prognostic factors. We conclude that
the prevalence of these ACS was 0.56%. The average age was 57 years with
a female predominance. Family history of early coronaropathy was the most
frequently risk factor (33%), followed by Smoking (16%), dyslipidemia
(16%), obesity (16%) and hypertension (8%). Diabetes was not found in any
patient. These patients had an ST elevation myocardial infarction (STEMI)
in 16% of cases vs 84% without ST elevation MI. The lateral location was
the most prevalent in 41% of cases. The mean peak of troponin was 8.6ng/
ml. The left ventricular dysfunction was detected in 5 cases. The echocar-
diography showed a case of mitral valve prosthesis dysfunction, a case of
hypertrophic cardiomyopathy. Aortic and mitral valvulopathy was detected
in 5 cases and an excellent hemodynamic profile was found in two cases.
The trans esophageal echocardiography showed 5 cases of left intra auric-
ular thrombus. The coronarography was normal in all patients. They
received the basic treatment of acute coronary syndrom. Atrial fibrillation
wasn’t tolerate in one case requiring pharmacologic cardioversion with good
evolution. Hyperthyroidism was detected in two patients and required anti-
thyroid therapy.
Conclusion: Coronary artery thromboembolism as a nonatherosclerotic
cause of acute coronary syndrom is a rare finding with unknown prevalence.
The cardiologist should be aware of possible coronary artery embolism when
the angiographic images are typical together with important thromboembolic
risk factors.
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Introduction: Myocardial healing after infarction is hampered by reperfu-
sion injury and ventricular remodeling, partly mediated by detrimental inflam-
matory responses via Toll-like Receptors (TLRs) signaling. We hypothesized
that modulation of the Triggering Receptor Expressed on Myeloid cells-1
(TREM-1), an amplifier of the innate inflammatory response, by the use of a
small synthetic peptide, namely LR-12, could improve myocardial injury in a
rat model of myocardial infarction.
Materials and methods: Wistar rats underwent either permanent occlu-
sion of the left coronary artery or transient ischemia for 60 minutes followed
by reperfusion. They were randomly assigned to receive LR-12 or vehicle for
5 days. Cardiac function and dimensions were assessed at baseline through
positron emission tomography (PET) imaging and 6 weeks after infarction by
PET and conductance catheter.
Results: Following permanent ischemia, LR-12 treatment significantly
reduced ventricular remodeling, as assessed by a lesser increase of end-diastolic
volume measured by PET (273±77 vs 198±95 μL; p=0.007), and improved the
systolic function: ESPVR (0.98±0.43 vs 1.45±0.49 mmHg.μL-1, p=0.04) or pre-
load recruitable stroke work PRSW (55±23 vs 80±34 mmHg.μL-1, p=0.03).
During transient ischemia, LR-12 infusion just before and for 5 days after
reperfusion also improved myocardial contractility assessed by conductance
catheter (PRSW: 64±25 vs 96±26 mmHg.μL-1, p=0.02; ESPVR 1.00±0.30 vs
1.61±0.69 mmHg.μL–1, p=0.05).
Discussion: Activation of immune response after myocardial infarction is
a double-edged sword: mandatory for wound healing, but deleterious during
reperfusion injury and ventricular remodeling. Inhibition of TREM-1 with LR-
12 does not inhibit inflammation but modulates the amplification of the
inflammatory response.
Conclusion: LR-12, by inhibiting TREM-1, improves ventricular remod-
eling and myocardial contractility in different experimental models of myocar-
dial infarction.
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Introduction: The optimal timing of coronary intervention in patients with
non–ST-segment elevation acute coronary syndromes (NSTE-ACSs) is a
matter of debate.
Purpose: We proposed through this work to study the optimal time to cor-
onary angiography in patients admitted for acute coronary syndrome without
ST-segment elevation in the Tunisian context and its prognostic impact on in-
hospital mortality.
Materials and methods: It is about an observational study from
MIRACOS registry that included 407 patients admitted for NSTE-ACS. We
were interested to find general characteristics, the time to coronary angiog-
raphy, mortality and in-hospital complications.
Results: A total of 407 patients were included in our study. Nearly half
of our patients (49.5%) were considered at high cardiovascular risk. The
average to coronary angiography was 5.09 days. Patients who underwent
early coronary angiography were significantly younger (p=0.01), had a
lower incidence of diabetes (p=0.01), left heart failure (p=0.0001) and elec-
trical changes suggestive of ischemia (p=0.009). Patients who have under-
gone an invasive strategy had significantly lower levels of creatinine
(p<0.0001) and significantly lower GRACE score (p=0.0001). The absence
of renal failure, the absence of left ventricular failure, a low GRACE score
and the absence of anemia were independent predictors of use of an invasive
strategy. The overall mortality among patients included in the study was
2.9%. High heart rate (p=0.04), presence of heart failure (p=0.01), a high
serum creatinine (p<0.001) and GRACE score (p<0.0001) were predictors of
mortality in ACS ST (-) in our population. The group that underwent early
coronary angiography had a statistically significant reduction in MACE
(3.4% vs. 15.7%, p=0.04).
Conclusion: Despite the fact that our work has showed that invasive
strategy is associated with a better prognosis in ACS ST (-) patients, the use
of this strategy remains insufficient.
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